Aetna, Humana, Kaiser Permanente and the UnitedHeath Group will provide data for more than 5 billion medical claims to the Health Care Cost Institute (HCCI) to offer new insights into healthcare costs, utilization, and intensity.
Aetna, Humana, Kaiser Permanente and the UnitedHeath Group will provide data for more than 5 billion medical claims to the Health Care Cost Institute (HCCI) to offer new insights into healthcare costs, utilization, and intensity.
According to the newly formed nonprofit’s press release, “HCCI’s mission is to promote independent research and analysis on the causes of rising U.S. health spending; to provide policy makers, consumers, and researchers with better, more transparent information on what is driving healthcare costs; and to help ensure that, over time, the nation is able to get greater value from its health spending.”
The four insurers’ claim data represents more than $1 trillion of healthcare activity from more than 5,000 hospitals and 1 million service providers from calendar year 2000 through the present. Additionally, the commercial data will be updated regularly to ensure its usefulness for research purposes. Data will be de-identified in accordance with Health Insurance Portability and Accountability Act requirements.
HCCI will provide access to the data to accredited researchers whose proposals meet the organiation’s data and scientific usage standards. Beginning in 2012, HCCI plans to publish its own scorecards and supporting analysis on aggregate trends of healthcare cost and utilization.
Go back to the Managed Healthcare Executive eNews newsletter.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
Leadership Team at The Cigna Group Revamps in Efforts to Drive Growth, Enhance Customer Focus
March 13th 2025David M. Cordani, chairman and CEO of The Cigna Group, expressed that these moves were made to “build upon our strengths for continued growth, enhance our customer focus, and deliver even greater value for those we serve."
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Navitus to Offer Unbranded Stelara Biosimilar, Remove Stelara from Formulary
March 13th 2025Lumicera Health Services, Navitus’ specialty pharmacy, has made a deal with Teva to offer an unbranded biosimilar that they estimate will save $112,000 and $336,000 per patient per year. Navitus will remove Stelara from formulary on July 1, 2025.
Read More